Hematology Flashcards
Fanconi Anemia
- usually pancytopenias
- absent/abnormal thumbs
- other congenital anomalies
Diamond-Blackfan Anemia
macrocytic anemia usually in first year of life
lots of congenital anomalies
Transient Erythroblastopenia of Childhood (TEC)
self limited normocytic anemia between age 1-3
MDS can transform to
AML
Treatment of CML
Tyrosine kinase inhibitors (TKIs)
imatinib, dasatinib, and nilotinib
Polycythemia Vera
JAK 2 + low EPO
transform to AML
Rx phlebotomy, ASA, hydroxurea
Essential Thrombocytosis
1/2 of ppl will have JAK2 mutation
asymptomatic or vasomotor symptoms (HA, parathesias)
Common cause of reactive thrombocytosis
IDA
Essential Thrombocytosis Complications
thrombosis
hemorrhage
acquired VWD and increased bleeding risk
Treatment of Essential Thrombocytosis
hydroxyurea if >1,000,000
ASA for vasomotor/high risk
Primary Myelofibrosis Presentation
Usually symptomatic on presentation
- Cytokine-related hypercatabolic symptoms, such as fatigue, weight loss, fever, and chills
- Splenomegaly, abd distension
- extramedullary hematopoiesis
Primary Myelofibrosis Treatment
BMT
if JAK2 mutation, can use Ruxolitinib
Causes of Eosinophilia
CHINA C- collagen vascular disease H- Helminth infection (Strongyloides) I- idiopathic N- neoplasm; lymphomas and myeloproliferative A- allergy, atopy, asthma
Medications Associated with Eosinophilia
carbamazepine, sulfonamides
Hypereosinophilic Syndrome
eosinophils >1500
end-organ damage attributed to eosinophilia, typically affecting the skin, lungs, heart, gastrointestinal tract, and brain
Hypereosinophilic Syndrome Treatment
steroids
Definition of Acute Leukemias
more than 20% blasts
Acute promyelocytic leukemia
chromosomal translocation t(15;17)
treatment with all-trans retinoic acid
AML treatment
induction therapy with an anthracycline (such as daunorubicin) and infusional cytarabine.
ALL in adults
tends to be B cells
can have Philadelphia chromosome
can have CNS involvement
Anemia associated with CKD
Use darbopoetin/EPA for Hgb <10 in those with HD; do not increase to >11.5
However iron stores must be normal for EPA to work, so if low, administer iron prior to EPA
Screenings for adult survivors of leukemia
lipid profile
a1c/glucose
ECHO if anthracycline received
Elevated RBC association
thalassema
Corrected retic count
Retic % x hgb/normal hgb
normal hgb: 40 for women, 45 for men
MGUS
M protein less than 3
or less than 10% plasma cells on bone marrow
no end organ damage!
Multiple Myeloma - CRAB
Hypercalcemia
Renal Disease
Anemia
Bone Disease
Lenalidomide and pomalidomide adverse effects
VTE
Bortezomib AE
peripheral neuropathy
herpes zoster reactivation
Light chain amyloidosis
cardiac involvement is common
Waldenström macroglobulinemia (WM) i
indolent B cell lymphoma
secrete IgM
can develop hyperviscosity syndrome
Type I cryoglobulinemia
monoclonal immunoglobulin- usually IgM, associated with plasma cell dyscrasia
asymptomatic or hyperviscosity, thrombosis
Type II or III cryoglobulinemias
mixed
associated with hep C, connective tissue diseases
Treatment of skeletal lesions in multiple myeloma
Zoledronic acid and pamidronate
Treatment of acquired hypogammaglobulinemia associated with multiple myeloma
IVIG
will present with recurrent infections
Evaluating for bone lesions in smoldering multiple myeloma
Whole body MRI
Diagnosis of amyloidosis
if whole body symptoms- consider fat bad biopsy (less invasive)
otherwise, consideration of renal biopsy
5 Causes of Microcytic Hypoproliferative Anemia
F- IDA L - Lead poisoning A - ACD T - thalassemia S - sideroblastic anemia
IDA Symptoms (board question style)
PICA
Restless Leg Syndrome
Dysphagia due to esophageal web or stricture/Plummer-Vinson Syndrome
IDA Lab Tests
decreased Iron
Increased TIBC and transferrin
decreased transferrin sat
decreased ferritin
IDA- Oral Fe Treatment will work in
6 weeks; therapy for 3-6 months
Beta Thalassemia’s
Minor: 1 normal allele, microcytic anemia
Intermedia: ?
Major: deletion of both alelles; severe hemolytic microcytic anemia
Alpha Thalassemia’s
Minima: no abnormalities
Minor/Trait: microcytosis and/or anemia
Hemoglobin H: microcytic anemia w/ hemolysis
Hydrops Fatalis
Causes of Sideroblastic Anemia
Lead, Alcohol, Linezolid
MDS
Symptoms of Lead Poisoning
abdominal pain, motor neuropathy
Lead Poisoning Treatment
EDTA chelation
soluble transferrin receptor
elevated in IDA, normal in ACD
ACD Labs, differences from IDA
normal or elevated ferritin
normal or decreased TIBC
Causes of Normocytic Anemia
ACD, Renal Failure
Thyroid Disease
Aplastic Anemias, Pure Red Cell Aplasias
MDS, MM, etc
Teardrop cells
MDS
Methylmalonic acid and homocysteine
Both elevated in B12
Only homocysteine elevated in folate
Differential for Macrocytic Anemia
B12, folate, alcohol
MDS
Liver disease, hypothyroidism
Extravascular Hemolysis
- red cells removed by liver an spleen
- spherocytes on smear
- urine negative for Hgb and hemosiderin
Intravascular Hemolysis
- red cells lyse while in circulation
- urine positive for Hgb and hemosiderin
What is elevated reticulocyte count?
Greater than 2%
Spherocytes differential
Dat + AIHA
Dat - hereditary spherocytosis
Bite Cells
G6PD
Goal Ferritin level in Anemia of Renal Disease
> 100
transferrin saturation >20%
Pernicious Anemia Antibodies
parietal cells > intrinsic factor Ab
What can be determined on electrophoresis
alpha thal- Hemoglobin H
Sickle cell disease
all Beta thals
Treatment of Thalassemias
folate supplementation
avoid iron as easily overloaded
Congenital Hemolysis Syndromes
Sickle cells
hereditary spherocytosis
G6PD def
thals
G6PD Def Inheritance
X-linked; primarily in males
Drugs Use associated with TTP
cocacine, ectasy, oxomorphone
Primary Hemostasis
interaction between platelets, von Willebrand factor (vWF), and the vessel wall
Secondary Hemostasis
activation of coagulation factors that eventually lead to fibrin clot formation
PT evaluates
more sensitive to the effects of the vitamin K–dependent factors (II, VII, and X)
PTT evaluates
factors VIII, IX, XI, and XII.
Differential for prolonged PT
Factor VII deficiency
Vitamin K deficiency & Warfarin
Liver disease, DIC
Differential for prolonged PTT
Von Willebrand Disease
Def of VIII, IX, XI, XII
Heparin Exposure
Von Willebrand Factor Function
promotes platelet adhesion
functions as a protective carrier protein for factor VIII
VWF Evaluation
normal or prolonged PTT
prolonged closure time on the PFA-100
reduction in von Willebrand antigen (quantitative analysis) - less than 30%
reduced vWF ristocetin cofactor activity
Treatment of VWD
Type 1 - desmopression
Type 2b, 3 - factor concentrates
Active Bleeding in Liver Disease- treatment
treat to fibrinogen >100 and platelets >75
Acquired von Willebrand Disease Causes
high circulatory shear stress (valvular heart disease, hypertrophic cardiomyopathy, circulatory assist devices, and extracorporeal membrane-oxygenation system
Acquired Hemophilia
autoantibody directed against factor VII
often associated with pregnancy, autoimmune diseases, malignancy
DIC Lab Findings
prolonged PT, PTT
low fibrinogen, low platelets
elevated D-dimer
How to test for Thrombophilia
Stop anticoagulation for at least two weeks
What to consider for heparin resistance
antithrombin defiency
Most Common Causes of Thrombophilia
Factor V Leiden
Prothrombin G20210A Gene Mutation
Antithrombin Defiency
Protein C and Protein S act as
natural anticoagulants
Warfarin Induced Skin Necrosis, what commonly causes this…
Protein C deficiency
Antiphospholipid Syndrome Lab Abnormality
elevated PTT
Additional Evaluation of Budd-Chiari
usually associated with myeloproliferative neoplasm
consider screening including JAK2 mutation
Dabigatran MOA
direct thrombin inhibitor
NOAC Mechanisms
factor Xa inhibitors
Monitoring unfractionated heparin
PTT
Monitoring LMWH
Factor Xa if needed
Bridging/Overlapping Warfarin when initiating for acute DVT/PE
overlap for at least 5 days and until INR >2 for 24 hours
Heparin Antidote
protamine sulfate
Supratherapeutic INR while on warfarin - asymptomatic
4.5 - 10: Withhold
>10: Vitamin K 2.5mg
Supratherapeutic INR while on warfarin - symptomatic
vitamin k + four factor PCC
Idarucizumab
monoclonal antibody to reverse dabigatran
Therapetuic Level of Heparin, way to estimate…
1.5-2.5 x PTT
Chronic ITP Treatment During Pregnancy
Monitory unless platelets <30K
ALL Risk Factor
EBV, HIV/T-CL
CLL Risk Factors
Agent orange, first degree relatives
AML Symptoms
gingivial hyperplasia but no LAD or splenomegaly
AML Treatment
cytarabine + idarubicin
Vincristine side effects
neurotoxicity
Vinblastine side effects
blasts the bone marrow –> pancytopenic
Bleomycin side effects
lung toxicity/IPF
ALL treatment
1) BCR/ABL (t9:22) with imatinib
2) CD 20+ rituximab
3) CVAD (cyclophos, vincristine, Adriamycin/doxorubicin, dexameth)
ALL treatment for pediatrics includes
asaparaginase
Hairy Cell Leukemia specifics
older pts,
CDIIc+, dry tap
treat w/ Cladribine (2-Cda)
Indolent B Cell Lymphomas
Follicular
MALT
CLL
Hairy Cell
Aggressive B Cell Lymphomas
Diffuse B Cell Lymphoma
Mantle Cell
Burkitt
T Cell Lymphomas - Cutaneous
Myocosis fungoides
Searzy Syndrome
NLHs, cell type
B > T Cell
T Cell Lymphomas - Peripheral
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T Cell Lymphoma
Hodgkin’s Lymphoma - General
Bimodal, common in 2nd & 3rd decade
Biopsy shows Reed-Sternburg/Owls eye nodes
ABVD
doxorubicin
bleomycin
vincristine
dacarbazine
Hodgkins Lymphoma Treatment
ABVD
Follicular Lymphoma
B cell, t14:18
Treat with ritubixmab +/- CHOP
transform to large B cell lymphoma
CLL/SLL clinical pearls
associated with hypogammaglobulinemias, AIHA, ITP
can transform to large cell/Richter transformation
Hairy Cell Lymphoma Rx
Purine Nucleoside Agents (pentostatin + cladribine)
Diffuse Large Cell Lymphoma Rx
R-CHOP
Burkitt Lymphoma Types
Endemic/Africa/EBV
Sporadic/US w/ abd or pelvic involvement
HIV associatd
Burkitt Lymphoma Rx
Rituximab + CVAD
R-hyper CVAD
Lymphoblastic Lymphoma
T or B Cell; T more prevalent in peds
usually anterior mediastinal mass
Lymphoblastic Lymphoma Rx
CHOP +/- Rituximab
Use of bevacizumab
colon cancer + renal cell carcinoma
Mantle Cell Lymphoma
Cyclin D1, t(11:14), CD 19,20,5 positive
Treatment of Aplastic Anemia
Stem Cell Transplant
If not possible, immunosuppression
Causes (3) of Pure Red Cell Aplasia
- Parvovirus B19
- Thymoma
- large granular lymphocyte leukemia
MDS Treatment
cure: HPSCT
otherwise treatment is based on symptomatic cytopenias + reducing transformation to AML
transfusions, EPO stim, hypomethalating agents
MDS Agents for preventing progression to AML
hypometh: azacytidine and decitabine
5q - lenalidomide
Things that progress to AML
MDS, CMP, PV
CML associated chromosome
t9:22, Philadelphia, so can treat with imatinib
Acute Porphyria symptoms
- abd pain
- sensory & peripheral neuropathies w/ weakness
- ANS dysregulation
Acute Porphyria testing
urine porphilinogen
Colorectal genetic mutations associated with EGFR inhibitor (cetuximab and panitumumab) resistance
KRAS and NRAS
Most common indications for autologous HSCT
MM, relapsed NHL
Resected Pancreatitis Adjuvant Treatment
Chemotherapy (gemcitabine, capecitabine)
Tumor marker that is negative in pure seminoma
AFP
Common Causes of Vitamin K deficiency
Poor oral intake, antibiotics, malabsorption
Cold agglutinin hemolytic anemia treatment
Rituximab
CLL diagnostic test
peripheral blood flow cytometry
Androgen deprivation therapy equivalent treatments
Orchiectomy, GnRH agonist, GnRH antagonist
Treatment of factor VIII-inhibitor–related bleeding
factor VII
Rx AL Amyloidosis
Autologous HSCT
Transfusion-related infectious cause of hemolytic anemia
Babeiosa
Febrile Nonhemolytic Transfusion Rcxn Rx
leukoreduction
Atypical HUS Rx
Eculizumab
Chemotherapy & ATN
Cisplatin
CUP - isolated cervical lymphadenopathy
Head & Neck Cancer
ITP infectious causes
HIV
Hepatitis C
H pylori
Rx breast cancer + bone metases
chemo + bisphosphonates
Crizotinib
ALK and ROS1 + NSCLC
Types of SCD
Hb SS - SCD
Hb S - trait
Hb SC - hemoglobin C
Hb SB+ thal
Protein C associations
Vitamin K dependent
- warfarin induced skin necrosis
- thrombisis
- neonatal purpura fulminans
Sickle Cell Disease New Treatments
L-glutamine
Crizanlizumab
Paroxysmal Noctural Hemoglobinuria
unexplained hemolysis, thrombosis, pancytopenia
CD55 and CD59 def